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Laurent Kaiser, 3 and Olivier Preynat-Seauve 1, 2 BACKGROUND: Although the risk of transmitting infectious agents by blood transfusion is dramatically reduced after donor selection, leukoreduction, and laboratory testing, some could still be present in donor's blood. A description of metagenomes in blood products eligible for transfusion represents relevant information to evaluate the risk of pathogen transmission by transfusion.
STUDY DESIGN AND METHODS: Detection of
viruses, bacteria, and fungi genomes was made by highthroughput sequencing (HTS) of 600 manufactured blood products eligible for transfusion: 300 red blood cell (RBC) and 300 fresh-frozen plasma (FFP) units.
RESULTS: Anelloviruses and human pegivirus, frequent
in the blood of healthy individuals, were found. Human papillomavirus type 27 and Merkel cell polyomavirus, present on the skin, were also detected. Unexpectedly, astrovirus MLB2 was identified and characterized in a FFP unit. The presence of astrovirus MLB2 was confirmed in donor's blood and corresponded to an asymptomatic acute viremia. Sequences of bacteria and fungi were also detected; they are likely the result of environmental contamination.
CONCLUSION: This study demonstrates that HTS is a promising tool for detecting common and less frequent infectious pathogens in blood products V iruses, bacteria, and fungi are pathogens that can be transmitted by blood transfusion. Special attention is paid to viruses nowadays. To maximize prevention, subjects infected with well-known dangerous viruses are precluded from blood donation. As a matter of fact, many viruses can be found in blood. First, viruses may circulate in blood without inducing any symptoms. Among them, torque teno virus (TTV) is an anellovirus commonly detected in blood. blood donors [3] [4] [5] in accordance with a high prevalence worldwide. 6 Human pegivirus (HPgV) is another common virus, 7 with a prevalence estimated between 1.6 and 8.2%. 3, 8 A second group contains viremic viruses considered to have a potential worrisome impact on some categories of recipients and thus not systematically screened in donors (e.g., cytomegalovirus [CMV] , parvovirus B19, hepatitis E virus). A third group includes viruses never reported in blood and hence not screened in donors. High-throughput sequencing (HTS) has enabled studies of viral landscapes in clinical specimens 9 including blood. 10, 11 Some sequences of Anelloviridae, Herpesviridae, Picornaviridae, and Flaviviridae were found in blood of individuals ineligible for transfusion 12 and the presence of Anelloviridae and HPgV was reported in pooled plasma samples collected from high-risk subjects. 13 Anelloviridae and HPgV were also identified in plasma fractionation pools assembled from blood donors, with additional signatures corresponding to papillomavirus and gemycircularvirus. 14 Compositions of whole blood and manufactured blood products markedly differ. White blood cells (WBCs), possible vectors of virus transmission, are generally reduced in red blood cell (RBC) and fresh-frozen plasma (FFP) units. Hence, metagenomics analysis of viruses and of bacteria and fungi as well, present in final blood products eligible for blood transfusion, yields the most relevant data to assess the infectious status of blood products.
MATERIALS AND METHODS
Nucleic acid preparation, sequencing, and data analysis Nucleic acids were extracted from RBC and FFP units using a circulating nucleic acid kit (QIAamp, Qiagen). Pools were made of 30 nucleic acid extracts. DNA-Seq pools were treated with 1 U Klenow enzyme (NEB), 3 ng/ mL random primers, and 25 mmol/L dNTPs for 1.5 hours at 378C. DNA-Seq libraries were made using a DNA library kit (Nextera, Illumina). RNA-Seq pools were treated with DNase I (Ambion) for 30 minutes at 378C, ribodepleted, and amplified using a stranded total RNA with an rRNA removal kit (TruSeq and Ribo-zero gold, respectively, Illumina). In addition, RNA-Seq pools from RBCs were treated with a globin mRNA depletion kit (GLOBINclear, Ambion) to remove globin mRNA. Libraries were run on a sequencer (HiSeq 2500, Illumina) and paired-end reads of 100 nucleotides were analyzed using an updated version of the ezVIR pipeline. 9, 15 In this version, the SNAP aligner used in SURPI 16 19 was used to postfilter the human sequences remaining after ezVIR. The p1h1v Centrifuge index was made of human, viral, and approximately 4300 prokaryotic genomes. The same p1h1v index was also used to search for bacterial genomes in the sequencing pools.
Other methods are provided in the supplementary material (available as supporting information in the online version of this paper).
RESULTS

Validation of the experimental strategy
To ascertain the capacity of the HTS method to detect viral genomes in blood products, RBC or FFP units were spiked with one of the three following viruses: parvovirus B19, a single-stranded (ss) DNA virus, and two ssRNA viruses, namely, human rhinovirus 14 (HRV-14) and CDV, to validate the DNA-Seq and RNA-Seq protocols, respectively. Because it is not possible to estimate an average concentration of unexpected viruses in blood products, 10 5 copies/mL was considered a realistic value compatible with an efficient detection through regular polymerase chain reaction (PCR) methods. Reads were mapped to the human genome with ezVIR and Centrifuge. There were between 53 and 94% human sequences in those spiked samples (Fig. 1) . The unmapped reads were divided into low-complexity reads (e.g., dust filter) and nonhuman reads, with a variable recovery for nonhuman reads (between 4 and 44%; Fig. 1 ). Maximum read depth and percentage of genome coverage for those viruses are shown in Table 1 . Maximum read depth indicates the maximum number of reads assigned to a virus, in sliding windows of 50 bases along the genome of the virus. The percentage of genome coverage corresponds to the percentage of bases covered across the viral genome. All three viruses were covered at more than 99% (Table 1 and Fig. 2 ). The successful recovery of parvovirus B19 validated the efficiency of the Klenow polymerase treatment to convert ssDNA viral genomes into double-stranded (ds) DNA molecules ready to be sequenced ( Figs. 2A and 2B ). It is noteworthy that the maximum read depth values of CDV and HRV-14 were different from those observed for parvovirus B19 ( Table 1) , indicating that despite similar amounts of virions added to blood products, the sensitivity of detection differs between viruses. Maximum read depths for parvovirus B19 were similar in RBC and FFP units, with approximately 62 million and approximately 69 million reads sequenced, respectively ( Table 1 ), indicating that DNASeq was not influenced by the type of blood product. By contrast, maximum read depths from RNA-Seq were always higher in FFP when compared to RBCs, even though the total number of reads for RBCs spiked with HRV-14 or CDV was higher than those sequenced for FFP units (Table 1 ). For instance, maximum read depth for HRV-14 was higher (3703) in FFP when compared to RBCs (Figs. 2C and 2D ). The same observation was made for CDV (Figs. 2E and 2F). We found a genome coverage of more than 99% for CDV, with a higher maximum read of depth for FFP units when compared to RBCs (Table 1 ). This could be explained by the higher efficiency of nucleic acid extraction from FFP.
A negative control (e.g., saline buffer) was included to determine the background level due to possible viral contaminants present in reagents, columns, and sequencer. The nucleic acid extraction method is silica column based, but no contaminating viral sequences such as densovirus-like, circovirus-like, 20 and NIH-CQV parvovirus-like virus 21 were retrieved. In sum, the spiked controls showed good recovery of viral sequences, the level of detection being dependent on technical factors (e.g., sequencing type) and biologic factors (e.g., blood product type and virus identity).
Metagenomics analysis of a blood bank collection of 300 RBC and 300 FFP units
The studied RBC and FFP units were eligible for transfusion, distributed to the clinical units but not transfused for various practical reasons. A pooling scheme, with each pool corresponding to 30 nucleic acid extracts, was used to prepare the sequencing libraries (Fig. S1A , available as After DNA-seq, clusters for parvovirus B19 and anelloviruses (TTV, TTV-like minivirus, and small anellovirus) were frequently found ( Table 2 ). In addition, clusters corresponding to papillomavirus, Merkel cell polyomavirus (MCPyV), and several herpesviruses were also revealed ( Table 2 ). Prevalence of parvovirus B19 viremia is low (0.45%) 22 and detecting nine positive pools by DNA-Seq was not in agreement with its estimated prevalence. We performed real-time PCR on the pools of nucleic acids initially used for library construction and did not find any positivity for parvovirus B19 (not shown). The positive sequencing pools showed maximum read depths in the low range (one to 19 reads; Table 2 ) and the same parvovirus B19 nucleotide sequence was identified in all the positive pools, highly suggestive of a cross-contamination. Indeed, the sequencing run contained a plasma sample naturally infected by parvovirus B19. This specimen showed a very high mean read depth of more than 2 million ( Fig. S2A , available as supporting information in the online version of this paper) and was most likely the source of contamination. We did not use barcodes in the sequencing libraries and demultiplexing was not possible, illustrating the interest of barcoding strategies in sequencing pools of specimens.
To obtain the identity of the anelloviruses, sequencing reads were remapped with Bowtie2. In total, 11 pools were found to be positive, with nine of them initially found by ezVIR (Fig. 3A) . We detected the presence of up to eight anelloviruses in Pool J, in accordance with a high prevalence in humans (Fig. 3A) . We performed three specific PCRs against TTV, TTV midivirus, and TTV minivirus to validate these observations. Thirteen pools showed a clear positive signal with the three specific PCRs, and also with a universal TTV PCR, confirming the simultaneous presence of the three subfamilies (Fig. 3A) . Of note, the three groups of viruses were found in all the FFP pools (Pools H to N2) and less frequently observed in RBCs (Pools A2 to G). Five pools were found positive with PCR, but not with HTS, suggesting a lower sensitivity of HTS to detect anelloviruses when compared to PCR.
In the papillomavirus cluster, we observed reads corresponding to human papillomavirus 27 (HPV-27). HPV-27 was confirmed by PCR (Fig. S3A , available as supporting information in the online version of this paper) and Sanger sequencing (not shown) in four of the 20 initial pools. HPV-27 is frequent in cutaneous warts 23 and could be an environmental contamination (for instance from the skin). Fourteen RNA-Seq pools contained viral sequences (Table 3) . HPgV and hepatitis GB clusters were found in 11 pools, xenotropic MuLV-related virus in six pools, herpesvirus in two pools, parvovirus in one pool, and astrovirus in another one (Table 3 ). Validation of HPgV by nested PCR revealed six positive pools, with five pools overlapping with those found by RNA-Seq (Fig. 3B) . The discrepancies between PCR and RNA-Seq are most likely explained by the high level of HPgV (mean read depth, 100,123) recovered in the FFP unit naturally infected by parvovirus B19 (Fig. S2B) . We did not attempt to verify xenotropic MuLVrelated virus because it is a common contaminant of clinical specimens and even laboratory reagents. 24 To further expand the viral landscape, we used DIA-MOND and MMSeqs2 in order not to miss highly divergent viruses, based on translated amino acid alignment. We confirmed the presence of anelloviruses, HPgV, herpesviruses, papillomavirus, parvovirus, and astrovirus in the pools made from blood products (Tables S2 and S3 , available as supporting information in the online version of this paper). Specific reads matching to VP2 and VP3 proteins of a highly divergent Banna virus were revealed in two RNA-Seq pools (Tables S2 and S3) , further illustrating the possibility of detecting rare or emerging viruses.
In addition to viral sequences, we identified bacterial and fungal sequences commonly found in the environment. Of interest, most of the bacteria-positive pools were obtained from the RNA-Seq experiments (Table 4) . Reads corresponding to Propionibacterium acnes and Micrococcus luteus were frequently encountered whereas Staphylococcus epidermidis, Corynebacterium aurimucosum, and Cupriavidus metallidurans were found in some pools only (Table 4 and Fig. S4 , available as supporting information in the online version of this paper). Most of the fungipositive pools also matched to RNA-Seq experiments. Some sequences of S. cerevisiae, Exophiala oligosperma, Alternaria alternata, and Malassezia sympodialis were found in more than one pool (Table S4 , available as supporting information in the online version of this paper). Reads from Aureobasidium namibiae, Debaryomyces hansenii, and Penicillium expansum were revealed in specific pools (Table S4) , adding to the complexity of the blood product metagenomes. The summary of the metagenomics results is shown in Fig. 4 .
Detection of astrovirus MLB2 in a FFP unit
In Pool P, two viral clusters corresponding to astrovirus MLB2 and MCPyV were revealed (Table 3 and Fig. S5A , available as supporting information in the online version of this paper). MCPyV is highly prevalent in humans and part of the skin flora. 25 We validated its presence in three of 20 pools using PCR (Fig. S3B) , suggesting a contamination of blood products with the skin flora. Of interest, we also mapped 517 sequencing reads to astrovirus MLB2. The percentage of genome coverage was 29.1%, with 1781 nucleotides covered over a genome size of 6119 bp and with a maximum read depth of 72 (Fig. S5B) . Real-time reverse transcription (RT)-PCR confirmed the presence of astrovirus MLB2 in Pool P (data not shown). In addition, the 30 FFP units included in Pool P were individually tested and one sample was found positive (Table 5) . To exclude a possible contamination during nucleic acid purification or HTS, PCR was performed with a serum sample of the positive donor, collected the day of the donation and FFP production. The serum was revealed positive (Table 5) , therefore excluding any downstream contamination and consistent with a viremia in the donor. In addition, PCR performed with serum samples from the donor, obtained 6 and 12 months before the contaminated donation, and also 6 months after, showed the absence of astrovirus MLB2 (Table 5 ). These observations indicate a transient rather than persistent viremia. Five PCR products were obtained by using primers designed to cover the astrovirus MLB2 genome and sequenced by Sanger's method. By merging together the sequences of the PCR products with those assembled from reads obtained from RNA-Seq, an almost complete genomic sequence was obtained (MLB2-LIHT, Genbank KX022687), with only 40 bases lacking at the 5 0 end of the viral genome. A comparison to the reference sequence (NC_016155.1) revealed 99% identity (5997/6082 bp), with 82 nucleotides differences scattered along the viral genome. Four nonsynonymous mutations were located in ORF1a, one in ORF1b, and three in ORF2 (Fig. S6A) . One base in ORF2 was not resolved by Sanger sequencing (Position X, Fig. S6A , available as supporting information in the online version of this paper). Based on the International Committee on Taxonomy of Viruses guidelines, a phylogenic analysis of human astroviruses was made using the full-length amino acid sequences of ORF2 (Fig.  S6B ). This analysis showed that MLB2-LIHT clustered with MLB2 (GenBank YP_004934010.1), without forming a new subgroup. Of interest, astrovirus MLB2 was detected in several patients cared for in the hospital for diverse clinical manifestations, with astrovirus MLB2-Geneva 2014 (GenBank KT224358.1) discovered in a patient with meningitis. 26 We compared the sequences of MLB2-LIHT and MLB2-Geneva 2014, and found 58 differences along the 6072 nucleotides sequenced in common (Fig. S6C) . Taken together, the data suggest the presence of astrovirus MLB2 in the blood of a healthy blood donor.
DISCUSSION
By means of HTS and metagenomics, we revealed, in blood products eligible for transfusion, the presence of sequences corresponding to frequent and rare viruses and to some bacteria and fungi as well. TTV and HPgV are frequent viruses in human blood. Between 4 and 13% of blood donors were estimated to be positive in Switzerland. 27 Both viruses were found transmitted by transfusion in a minority of blood recipients. 28, 29 The highest level of HPgV was found in a FFP pool, in agreement with the association of extracellular viral particles with HPgV RNA. 30 More recently, a novel virus, human hepegivirus 1, which shares some characteristics with HPgV and hepatitis C virus, was detected in two serum samples of transfusion recipients. 31, 32 Bioinformatics analysis of the blood products did not reveal human hepegivirus 1, in accordance with its low transmission rate. 33 In addition, HPV-27 and MCPyV were found in blood products. Although some papillomavirus subtypes were described in the plasma of cancer patients, 34 they are generally considered not to spread within blood in asymptomatic subjects. On the other hand, HPV-27 has never been described in the blood. MCPyV has been found in plasma, but in immunosuppressed patients only. 35 Taken together, these arguments suggest a contamination with skin flora rather than viremia.
In addition to expected viruses, we found sequences of Banna virus, an emerging dsRNA virus initially isolated from the cerebrospinal fluid and sera of human patients with encephalitis. 36 Furthermore, an unexpected viral signature for astrovirus MLB2 was detected and validated in a plasma sample. Astrovirus MLB2 is a positive ssRNA virus belonging to Astroviridae and capable of infecting humans. 37, 38 Of interest, astrovirus MLB2 was recently found in the central nervous system and also in immunocompetent and immunocompromised subjects with disseminated infections. 26 Other astroviruses were also reported pathogenic. For instance, VA1 was found in stool, serum, and cerebrospinal fluid of a 18-month case of encephalopathy following stem cell transplantation 39 and in the brain biopsy of a 42-year-old immunocompromised man who died from neurologic deterioration after allogeneic bone marrow transplantation. 40 In addition to VA1, 41 MLB1 42 and HAstV-4 43 were also detected in the cerebrospinal fluid and brain biopsy of male patients suffering from encephalitis. 41, 43 In addition to viral sequences, we also identified bacterial and fungal sequences. We think that the latter are likely to be due to environmental contamination. In a recent study, P. acnes was found in 23% of blood donations, S. epidermidis in 38%, and M. luteus in 5%. 44 P. acnes is one of the most common bacterial species reported when blood products for transfusion are studied. 45, 46 It should be noticed, however, that metagenomics analysis of leukemia patients showed bacterial reads for P. acnes, Staphylococcus spp., and Corynebacterium spp. 47 and that C. aurimucosum was identified in a patient with a urinary tract infection 48 and C. metallidurans in a patient suffering from nosocomial septicemia. 49 Regarding fungi, E. oligosperma was implicated in cutaneous mycoses 50 and A. alternata was found on normal human skin and during cutaneous infections, 51 again illustrating a possible contamination of cutaneous origin at any stage, whether during blood collection, blood product preparation, or sequencing. It should be noticed however that Malassezia sp. were reported in a metagenomics analysis of blood samples of hematologic patients 47 but
were also found on the skin, together with Aureobasidium pullulans. 52 Finally, blood invasive infections have been described for D. hansenii and S. cerevisiae.
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One important limitation of HTS is its uncharacterized sensitivity. It would be a huge task to determine the sensitivity of detection for all referenced human pathogens one by one, and this would done for known ones only. Thus, HTS cannot ensure the absence of infectious risk in case of a negative screen. The sensitivity of the whole process is dependent on numerous factors including: 1) technical efficiency of nucleic acid extraction; 2) pathogen localization (RBCs, plasma, residual WBCs); and 3) sequencing experiment. For example, positive controls suggested that depth of sequencing with FFP units is higher than with RBCs. This could be at least in part due to a better nucleic acid extraction from plasma. In addition, it is very likely that many pathogens are still uncharacterized, resulting in incomplete databases of reference sequences.
In this study, overlooked viral pathogens can be observed, stressing the necessity to pursue such screening in larger collections. This is reinforced by the fact that transfusion is frequently used in the setting of immunodeficiency. It is noteworthy that dissemination of astrovirus infection was shown in children with severe primary combined immunodeficiency and after allogeneic hematopoietic stem cell transplantation. 55 In conclusion, this study demonstrates that HTS is a suitable and promising tool for a large screening of infectious agents in blood products, improving epidemiologic monitoring. 
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online version of this article at the publisher's website. Table S1 . Primers used for astrovirus MLB2 sequencing. Table S2 . Analysis of viruses using DIAMOND. Table S3 . Analysis of viruses using MMSeqs2. Table S4 . Detection of fungi. Fig. S1 . Experimental design for high-throughput sequencing of viruses. A. Sequencing strategy to characterize the viral landscape of blood products. Nucleic acids from 300 RBC concentrates and 300 FFP units were extracted and 20 pools containing 30 individual samples were made for DNA-Seq and RNA-Seq. Pools for DNA-Seq were treated with RNAse A to remove RNAs, and with Klenow fragment to obtain double-stranded nucleic acids from singlestranded DNAs. A rRNA depletion was performed before reverse-transcription of the pools used for RNA-Seq. For RBC, an extra step consisting in globin mRNA reduction was made. Libraries for DNA-Seq were constructed with Nextera technology whereas RNA-Seq libraries were made with the Illumina TruSeq protocol. B. Pie charts of sequencing reads. The 20 FFP and 20 RBC libraries are shown on the left and right parts of the panel, respectively. The percentage of sequencing reads mapped to the human genome, nonmapped to the human genome, and those of lowcomplexity, are indicated by salmon, green and blue colors respectively. Fig. S2 . Coverage plots of reads mapped to parvovirus and HPgV in the FFP naturally infected by parvovirus B19. A. Reads mapping to NC_000883.2 (parvovirus B19) were used to generate the coverage plot. B. Reads mapping to U44402.1 (HPgV) were used for the coverage plot. Percentage of genome coverage and maximum read depth are indicated at the top of the plots. The x-axis indicates the genomic coordinates (5' to 3') whereas the y-axis shows the read depth at each position of the genome. Fig. S3 . PCR validation of HPV-27 and Merkel cell polyomavirus. A. HPV-27 PCR. The original pools were analyzed by PCR for the presence of HPV-27. The expected amplicon size is 480 base pairs (based on AB211993.1). Specificity was confirmed by sequencing each band found at the expected size. B. Merkel cell polyomavirus PCR. Pools of nucleic acids were analyzed by PCR for the presence of Merkel cell polyomavirus. The bands at 154 base pairs (based on EU375803.1) were excised from the agarose gels and purified. PCR specificity was assessed by Sanger sequencing the individual purified products. Fig. S4 . Examples of coverage plots for sequencing reads mapped to bacteria. A. Reads mapping to propionibacterium acnes (NC_006085) in pool E were used to generate the coverage plot. B. Reads mapping to propionibacterium acnes (NC_006085) in pool G. C. Reads mapping to micrococcus luteus (NC_012803) in pool F2. D. Reads mapping to micrococcus luteus (NC_012803) in pool K2. E. Reads mapping to staphylococcus epidermidis (NC_004461) in pool J2. F. Reads mapping to cupriavidus metallidurans (NC_007973) in pool C2. The x-axis indicates the genomic coordinates (in kb) and the y-axis corresponds to the read depth at each position of the bacterial genome. 
